Edgewise Therapeutics Inc

EWTX NASDAQ Healthcare & Biotech United States US28036F1057
45.44 $
4.15 %

Edgewise Therapeutics develops innovative therapies for severe muscle diseases, with a focus on controlling muscle contraction.